Australian breast cancer study seeks participants

NewsGuard 100/100 Score

RMIT University researchers are seeking healthy, postmenopausal women to participate in a study to determine if diet and lifestyle can reduce the risk breast cancer.

"Previous research indicates that flaxseed may contain compounds that protect postmenopausal women from breast cancer," Leah Williamson, a postgraduate researcher at RMIT's Department of Food Science, said.

"These compounds, called phytoestrogens, work at lowering levels of estrogens linked to breast cancer. Flaxseed is particularly high in one such phytoestrogen, lignan, which is believed to reduce the enzymes and the estrogens that cause the breast to produce potentially cancerous cells.

"We are collaborating with Melrose Laboratories to study the potential benefits of flaxseed in reducing the risk of breast cancer and the time it takes to do so."

One in 10 Australian women develops breast cancer, making it the most common cancer and one of the most prevalent diseases in Australian women.

"The aim of the research is to assess the relationship between flaxseed and breast cancer, and to suggest diets that can be incorporated into the lifestyle of women at risk," Ms Williamson said. "Our goal is to lower breast cancer risk and to improve long-term quality of life."

The study, titled "Time taken for Flaxseed Lignans to Effect Biomarkers of Breast Cancer Risk in Postmenopausal Women", is seeking postmenopausal women in metropolitan Melbourne. Participants must be healthy, not on hormone replacement therapy, non-smokers and at least one year menopausal.

In addition to consuming their normal Western diet, fewer than five alcoholic drinks per week and no more than three caffeinated beverages per day, the women will provide urine and blood samples for evaluation.

Their body weights will be measured and self-reported diet records monitored.

Women interested in taking part in the study should contact Leah Williamson on (03) 9925 3967 or [email protected]

Media interviews: Leah Williamson (03) 9925 3967 or 0422 505 124

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New trials show promise for immune checkpoint blockers in early-stage lung cancer